ACCESSWIRE

As companies face the task of determining how to best bring some employees back to the workplace, here are five PR strategies to keep in mind when communicating. ow.ly/eI4p50zZQPR #WorkFromHome #WFH #PublicRelations

🎀 We’re proud to lace up our sneakers and join the Susan G. Komen Walk in Nashville! At ACCESSWIRE, giving back is in our DNA. Together, we’re stronger! #BreastCancerAwareness #WalkForACure #ACCESSWIRECares #StrongerTogether 🎗️

👀 Want to know how data can elevate your PR game and prove your ROI? Dive in and discover how modern PR is creating real business impact. Read the Blog Now! ow.ly/tkus50TBQ4f #PRTrends #DataDrivenPR #PublicRelations #MediaMonitoring #PRInsights #DigitalPR

Exciting insights from our New Healthcare Trend Report are now here! Download your report today! accesswire.com/healthcare-rep… What are your thoughts on these trends? Share with us using #healthcaretrends #healthcarepr #pharmainnovation #PublicRelations

Aytu BioPharma (@AytuBioPharma_) to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024 ow.ly/EfNF50Trnw6

Petros Pharmaceuticals (@PetrosPharma) Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) ow.ly/JSeA50Tl5gP

Envela (@EnvelaCorp) to Participate at the Lake Street Best Ideas Growth Conference ow.ly/NEWI50T9KpH

AYRO (@AyroInc) Appoints New Management Team to Re-Engineer and Revamp a Lower Cost Low-Speed Electric Vehicle ow.ly/QQsU50T352Q

Full Alliance Group, Inc. (@OTCFAGI) (OTC: FAGI) Wholly Owned Subsidiary Dynamaxx Health Inc. Secures Its Own Manufacturing Contract for Medical Devices for MAXX Health Clinics ow.ly/l0Og50SXK09

Aytu BioPharma (@AytuBioPharma_) to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024 ow.ly/I0lm50SUP9h

FSD Pharma (@FsdPharma) Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team ow.ly/iBvT50SUP32

Idaho Strategic (@IdahoStrategic) Receives Grant Funding to Support Power Infrastructure Upgrades to the Golden Chest Mine ow.ly/6yXq50SU9nL

Envela (@EnvelaCorp) Reports Second Quarter 2024 Financial Results ow.ly/PKuo50STmgA

Aytu BioPharma (@AytuBioPharma_) Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations ow.ly/P7Eo50SS3i4

Envela (@EnvelaCorp) to Announce Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 ow.ly/sHNh50SOcO6

Petros Pharmaceuticals' (@PetrosPharma) Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) ow.ly/f93650SMn8Q

Paragon Technologies Recommends Ocean Power Shareholders Vote AGAINST the Company's Plan to Increase Its Authorized Shares and Hold the Board Accountable for Its Wasteful Spending That Leads to Increasing Losses ow.ly/qhlb50SLLOe

IotaComm (@iotacomm) Announces Appointment of New Board Member and Key Corporate Actions accesswire.com/892366/iotacom…

Idaho Strategic (@IdahoStrategic) to Present at the MicroCap Leadership Summit and Provide Attendees with a Tour of the Golden Chest Mine ow.ly/3IjL50SI44I

Petros Pharmaceuticals’ (@PetrosPharma) STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance ow.ly/O2Zu50SCile

FSD Pharma (@FsdPharma) Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia ow.ly/2YI550SsUXm